EOLAS THERAPEUTICS INC has a total of 28 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Argentina and Taiwan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CHARRIER JEAN-DAMIEN, HIMMELSBACH FRANK and MIIKANA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Argentina | 3 | |
#3 | Taiwan | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Philippines | 2 | |
#7 | Uruguay | 2 | |
#8 | Australia | 1 | |
#9 | Canada | 1 | |
#10 | China | 1 | |
#11 | Hong Kong | 1 | |
#12 | Israel | 1 | |
#13 | Republic of Korea | 1 | |
#14 | Mexico | 1 | |
#15 | New Zealand | 1 | |
#16 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Jiang Rong | 15 |
#2 | Song Xinyi | 15 |
#3 | Kamenecka Theodore M | 12 |
#4 | He Yuanjun | 12 |
#5 | Kamenecka Theodore | 11 |
#6 | Herr Robert Jason | 5 |
#7 | Nguyen William | 5 |
#8 | Jiang Qin | 5 |
#9 | Yuanjun He | 4 |
#10 | Theodore Kamenecka | 3 |
Publication | Filing date | Title |
---|---|---|
TW201613902A | Difluoropyrrolidines as orexin receptor modulators | |
TW201613891A | Substituted prolines / piperidines as orexin receptor antagonists | |
US2014364433A1 | Substituted prolines/piperidines as orexin receptor antagonists | |
NZ628491A | Substituted prolines / piperidines as orexin receptor antagonists |